Pfizer officially seeks FDA clearance for coronavirus vaccine in children
The companies’ application starts a pressure-packed FDA review that could open up COVID-19 shots for tens of million Americans between the ages of 5 and 11.
The companies’ application starts a pressure-packed FDA review that could open up COVID-19 shots for tens of million Americans between the ages of 5 and 11.